Prevail Therapeutics Inc. | Uncategorized | Business Contracts

Tender and Support Agreement, dated December 14, 2020, by and among Eli Lilly and Company, Tyto Acquisition Corporation, Pontifax (Cayman) V L.P., Pontifax (China) V L.P.,... (Filed With SEC on December 15, 2020)

Tender and Support Agreement, dated December 14, 2020, by and among Eli Lilly and Company, Tyto Acquisition Corporation and Asa Abeliovich, M.D., Ph.D (Filed With SEC on December 15, 2020)

Form of Contingent Value Right Agreement, by and among Eli Lilly and Company, Tyto Acquisition Corporation and a rights agent mutually agreeable to Eli Lilly and Company and... (Filed With SEC on December 15, 2020)

Open Market Sale AgreementSM dated as of August 11, 2020 by and between Prevail Therapeutics Inc. and Jefferies LLC (Filed With SEC on August 11, 2020)

Description of Registrant's Securities (Filed With SEC on March 26, 2020)

Form of Indemnity Agreement between Registrant and each of its directors and executive officers (Filed With SEC on May 24, 2019)

Offer letter, dated September 15, 2017, between Registrant and Asa Abeliovich, M.D., Ph.D (Filed With SEC on May 24, 2019)

Offer letter, dated March 1, 2018, between Registrant and Jeffrey Sevigny, M.D (Filed With SEC on May 24, 2019)

Offer letter, dated February 26, 2018, between Registrant and Franz Hefti, Ph.D (Filed With SEC on May 24, 2019)

Prevail Therapeutics Inc. (26) | Uncategorized (9)